• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童库欣综合征治疗后的生活质量和其他结果。

Quality of life and other outcomes in children treated for Cushing syndrome.

机构信息

Section on Endocrinology Genetics, Program on Developmental Endocrinology Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Clin Endocrinol Metab. 2013 Jul;98(7):2667-78. doi: 10.1210/jc.2013-1123. Epub 2013 May 2.

DOI:10.1210/jc.2013-1123
PMID:23640970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3701267/
Abstract

CONTEXT

Cushing syndrome (CS) in children is associated with residual impairment in measures of health-related quality of life, even after successful resolution of hypercortisolemia, highlighting the need for early identification of morbidities and improvements in long-term management of these patients.

EVIDENCE ACQUISITION AND SYNTHESIS

A PubMed, Scopus, and Web of Science search of articles from 1900 onward identified available studies related to quality of life and complications of pediatric CS as well as important historical articles. This review summarizes studies through November 2012 and highlights recent developments.

CONCLUSIONS

A review of the literature identifies significant morbidities associated with CS of pediatric onset, which must not be treated in isolation. CS affects children and adolescents in many ways that are different than adults. Post-treatment challenges for the child or adolescent treated for CS include: optimize growth and pubertal development, normalize body composition, and promote psychological health and cognitive maturation. All these factors impact health-related quality of life, which is an important outcome measure to assess the burden of disease as well as the effect of treatment. Future research efforts are needed to improve management of the physical, psychological, and emotional aspects of this disease in order to diminish the residual impairments experienced by the pediatric CS patient population.

摘要

背景

儿童库欣综合征(CS)与健康相关生活质量的衡量标准存在残余损害相关,即使在皮质醇过多症成功解决后也是如此,这突出表明需要早期识别病态,并改善这些患者的长期管理。

证据获取和综合

对 1900 年以来 PubMed、Scopus 和 Web of Science 中与儿童 CS 的生活质量和并发症相关的现有研究以及重要的历史文献进行了搜索。本综述总结了截至 2012 年 11 月的研究,并强调了最近的发展。

结论

对文献的回顾确定了与儿科 CS 相关的重大病态,这些病态绝不能孤立地对待。CS 以不同于成年人的方式影响儿童和青少年。接受 CS 治疗的儿童或青少年的治疗后挑战包括:优化生长和青春期发育、使身体成分正常化、促进心理健康和认知成熟。所有这些因素都影响健康相关的生活质量,这是评估疾病负担以及治疗效果的重要结果衡量标准。需要开展未来的研究工作,以改善这种疾病的身体、心理和情感方面的管理,从而减少儿科 CS 患者群体所经历的残余损害。

相似文献

1
Quality of life and other outcomes in children treated for Cushing syndrome.儿童库欣综合征治疗后的生活质量和其他结果。
J Clin Endocrinol Metab. 2013 Jul;98(7):2667-78. doi: 10.1210/jc.2013-1123. Epub 2013 May 2.
2
Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study.库欣综合征治愈1年后儿童和青少年的生活质量:一项前瞻性研究。
Clin Endocrinol (Oxf). 2009 Sep;71(3):326-33. doi: 10.1111/j.1365-2265.2008.03515.x. Epub 2008 Dec 17.
3
Prognosis of patients treated for Cushing syndrome.库欣综合征患者的治疗预后。
Endocrinol Nutr. 2014 Jan;61(1):52-61. doi: 10.1016/j.endonu.2013.03.008. Epub 2013 Jul 3.
4
Holistic burden of illness in patients with endogenous Cushing's syndrome: A systematic literature review.内源性库欣综合征患者的整体疾病负担:系统文献回顾。
Endocrinol Diabetes Metab. 2024 Jan;7(1):e464. doi: 10.1002/edm2.464. Epub 2023 Dec 20.
5
Improvement but No Normalization of Quality of Life and Cognitive Functioning After Treatment of Cushing Syndrome.治疗库欣综合征后生活质量和认知功能的改善但未恢复正常。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5325-5337. doi: 10.1210/jc.2019-01054.
6
Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into young adulthood.儿童及青少年期起病的内源性库欣综合征对骨量、身体成分和生长的影响:一项针对青年期的7年前瞻性研究。
J Bone Miner Res. 2007 Jan;22(1):110-8. doi: 10.1359/jbmr.061010.
7
Cushing's syndrome: a structured short- and long-term management plan for patients in remission.库欣综合征:缓解期患者的结构化短期和长期管理方案。
Eur J Endocrinol. 2013 Oct 4;169(5):R139-52. doi: 10.1530/EJE-13-0534. Print 2013 Nov.
8
Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndrome.内源性儿科库欣综合征患者常出现淋巴细胞减少和感染风险增加。
Pediatr Res. 2018 Feb;83(2):431-437. doi: 10.1038/pr.2017.278. Epub 2017 Dec 6.
9
An update on Cushing syndrome in pediatrics.儿童库欣综合征的最新进展。
Ann Endocrinol (Paris). 2018 Jun;79(3):125-131. doi: 10.1016/j.ando.2018.03.010. Epub 2018 Apr 9.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
Adrenal Cushing's syndrome in children.儿童库欣综合征。
Front Endocrinol (Lausanne). 2023 Dec 12;14:1329082. doi: 10.3389/fendo.2023.1329082. eCollection 2023.
2
Germline PRKACA amplification-associated primary pigmented nodular adrenocortical disease: a case report and literature review.胚系 PRKACA 扩增相关的原发性色素性结节性肾上腺皮质疾病:病例报告及文献复习。
Arch Endocrinol Metab. 2023 Nov 17;68:e220491. doi: 10.20945/2359-4292-2022-0491.
3
Cushing disease in pediatrics: an update.小儿库欣病:最新进展
Ann Pediatr Endocrinol Metab. 2023 Jun;28(2):87-97. doi: 10.6065/apem.2346074.037. Epub 2023 Jun 30.
4
Diagnosis, Manifestations, Laboratory Investigations, and Prognosis in Pediatric and Adult Cushing's Disease in a Large Center in China.中国一大型医疗中心儿童和成人库欣病的诊断、临床表现、实验室检查及预后
Front Endocrinol (Lausanne). 2021 Nov 19;12:749246. doi: 10.3389/fendo.2021.749246. eCollection 2021.
5
Quality of Life in Patients With Cushing's Disease.库欣病患者的生活质量
Front Endocrinol (Lausanne). 2019 Dec 11;10:862. doi: 10.3389/fendo.2019.00862. eCollection 2019.
6
Optical Imaging Technology: A Useful Tool to Identify Remission in Cushing Disease After Surgery.光学成像技术:一种用于识别库欣病术后缓解情况的有用工具。
Horm Metab Res. 2019 Feb;51(2):120-126. doi: 10.1055/a-0801-8917. Epub 2019 Jan 2.
7
Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushing's syndrome.罕见病患者报告结局挑战及解决方案的图示:库欣综合征的系统评价
Orphanet J Rare Dis. 2018 Dec 19;13(1):228. doi: 10.1186/s13023-018-0958-4.
8
Cushing's Syndrome in Pediatrics: An Update.儿童库欣综合征:最新进展。
Endocrinol Metab Clin North Am. 2018 Jun;47(2):451-462. doi: 10.1016/j.ecl.2018.02.008.
9
Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.新生儿库欣综合征:一种罕见但可能具有毁灭性的疾病。
Clin Perinatol. 2018 Mar;45(1):103-118. doi: 10.1016/j.clp.2017.10.002. Epub 2017 Dec 12.
10
Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndrome.内源性儿科库欣综合征患者常出现淋巴细胞减少和感染风险增加。
Pediatr Res. 2018 Feb;83(2):431-437. doi: 10.1038/pr.2017.278. Epub 2017 Dec 6.

本文引用的文献

1
Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients.原发性空蝶鞍患者垂体功能障碍与心血管风险的关系。
Clin Endocrinol (Oxf). 2013 Aug;79(2):211-6. doi: 10.1111/cen.12122. Epub 2013 May 6.
2
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center.一家中心 76 例库欣病患者中米托坦的疗效和耐受性。
Eur J Endocrinol. 2012 Oct;167(4):473-81. doi: 10.1530/EJE-12-0358. Epub 2012 Jul 19.
3
The burden of Cushing's disease: clinical and health-related quality of life aspects.库欣病的负担:临床和与健康相关的生活质量方面。
Eur J Endocrinol. 2012 Sep;167(3):311-26. doi: 10.1530/EJE-11-1095. Epub 2012 Jun 22.
4
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.库欣综合征并发症的流行病学、发病机制和治疗进展。
J Endocrinol Invest. 2012 Apr;35(4):434-48. doi: 10.1007/BF03345431.
5
Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review.依托咪酯治疗库欣综合征高皮质醇血症的研究进展。
Eur J Endocrinol. 2012 Aug;167(2):137-43. doi: 10.1530/EJE-12-0274. Epub 2012 May 10.
6
Clinical consequences of Cushing's syndrome.库欣综合征的临床后果。
Pituitary. 2012 Sep;15(3):319-29. doi: 10.1007/s11102-012-0394-8.
7
Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.米非司酮,一种糖皮质激素受体拮抗剂,可给库欣综合征患者带来临床和代谢获益。
J Clin Endocrinol Metab. 2012 Jun;97(6):2039-49. doi: 10.1210/jc.2011-3350. Epub 2012 Mar 30.
8
Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease.儿童和青少年库欣病手术治愈后下丘脑-垂体-肾上腺轴的恢复。
J Clin Endocrinol Metab. 2012 May;97(5):1483-91. doi: 10.1210/jc.2011-2325. Epub 2012 Mar 7.
9
A 12-month phase 3 study of pasireotide in Cushing's disease.一项为期 12 个月的培塞利肽治疗库欣病的 3 期研究。
N Engl J Med. 2012 Mar 8;366(10):914-24. doi: 10.1056/NEJMoa1105743.
10
Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome.库欣综合征患者的言语和视觉记忆表现以及海马体积的 3 特斯拉磁共振成像测量。
J Clin Endocrinol Metab. 2012 Feb;97(2):663-71. doi: 10.1210/jc.2011-2231. Epub 2011 Dec 7.